Moshe Alafi Net Worth & Insider Trades

Moshe Alafi Intra-Cellular Therapies, Inc

As of October 3, 2017

What is Moshe Alafi's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's Moshe Alafi is estimated to be about $198.06M . Moshe Alafi owns about 3,953,270 units of Intra-Cellular Therapies, Inc common stock. In the last 3 years at Intra-Cellular Therapies, Inc, Moshe Alafi has sold an estimated value of $100.01K worth.

What is Moshe Alafi's Past Insider Trading?

Moshe Alafi's largest purchase order was 258,065 units , worth over $4M on October 3, 2017. Moshe Alafi's largest sale order was 15,742 units , worth over $100.01K on July 10, 2014. In total, Moshe Alafi has made about 9 transactions over 3 years of their time at Intra-Cellular Therapies, Inc. Moshe Alafi usually trades in November, with the busiest year in 2014.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Moshe Alafi's' Mailing Address?

  • Mailing address is 1311 Orleans Drive Sunnyvale CA 94089 CA

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on September 19, 2023 by Sharon Mates who sold 100,000 units worth $5.39M . In the last 9 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $137.34M and bought an estimated value of $69.16M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...